The RespiRx, the first inhalable nicotine-replacement therapy, gains IND clearance.Read More
The RespiRx, the first inhalable nicotine-replacement therapy, gains IND clearance.Read More
The former CTP director said the nicotine inhalation product could be a “game changer."Read More
Respira has appointed Brian W. Quigley, a 16 year veteran of Altria Group, as its Chief Operating Officer. Read More